TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Tryptamine Therapeutics ( (AU:TYP) ).
Tryptamine Therapeutics Limited has announced a change in the director’s interest, specifically for Jason Carroll, through the allotment of capital raising shares and options. The company has increased its ordinary fully paid shares by 15 million and options by 7.5 million, as approved by shareholders, which reflects a strategic move to bolster its capital structure.
More about Tryptamine Therapeutics
YTD Price Performance: -15.79%
Average Trading Volume: 1,658,752
Technical Sentiment Signal: Buy
Current Market Cap: A$40.85M
For an in-depth examination of TYP stock, go to TipRanks’ Stock Analysis page.